☆ 4.6 Article

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

EXPERIMENTAL DERMATOLOGY (2016)

Journal

EXPERIMENTAL DERMATOLOGY

Volume 25, Issue 5, Pages 397-399

Publisher

WILEY-BLACKWELL

DOI: 10.1111/exd.12949

Keywords

extramammary Paget's disease; M2 macrophages; RANKL/RANK; tolerance

Funding

Grants-in-Aid for Scientific Research [16K19703] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Journal

EXPERIMENTAL DERMATOLOGY

Publisher

WILEY-BLACKWELL

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Journal

EXPERIMENTAL DERMATOLOGY

Publisher

WILEY-BLACKWELL

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper